Lecture 17: Corticosteroid drugs Flashcards

1
Q

Therapuetic use of corticosteroids

A

-primary adrenal insufficiency
-allergic reactions
-inflammation/autoimmune diseases
-asthma
-anti-cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Allergic reactions treated by corticosteroids

A

-insect stings
-angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

inflammation and autoimmune diseases treated by corticosteroids

A

-burstitits, synovitis, tendonitis
-rheumatoid arthritis
-lupus
-IBS
-chronic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cortisol

A

-active form
-11 hydroxyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cortisone

A

-inactive form
-11 hydroxyl oxidized to ketone
-effective as cortisol
-do not give to patients with impaired livers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

11 B-hydroxysteroid dehydrogenase

A

-catalyzes oxidation of cortisol to cortisone
-reversible reaction
-in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Short acting corticosteroids (8-12hr)

A

-hydrocortisone
-cortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

intermediate acting corticosteroids (12-36hr)

A

-prednisone
-prednisolone
-methylprednisolone
-triamcinolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

long-acting corticosteroids (36-54hr)

A

-dexamethasone
-betamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Synthetic glucocorticoids

A

-fludrocortisone
-prednisone/prednisolone
-methylprednisone
-triamcinolone
-dexamethasone
-betamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fludrocortisone

A

-a-Florine at C-9
-greater glucocorticoid activity
-strong mineralcorticoid activity
-intense Na+ retention that leads to edema
-used in MC therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prednisone/Prednisolone

A

-double bond between C1 and C2
-more GC activity
-reduced MC activity
-interconvertable by 11B-hydroxysteroid dehydrogenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

11B-hydroxysteroid dehydrogenase

A

-converts prednisone to prednisolone and vice versa
-11B OH to =O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Methylprednisolone

A

-6a-methyl group
-similar potency to prednisolone
-reduced MC activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Triamcinolone

A

-9a-F and 16a-OH
-similar to prednisone
-reduced MC activity
-inc hydroPHILIcity
-low oral bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dexamethasone

A

-16a-methyl group
-inc lipoHILIcity = inc binding = stronger effect
-inc stability in plasma
-reduced MC activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Betamethasone

A

-enantiomer of dexamethasone at C-16
-similar properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

21-esters

A

-21-hydroxyl group modified to ester
-prodrugs activated by hydrolysis by esterases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

21-ester groups

A

-acetate or butyrate
-succinate
-phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

21- acetate or butyrate

A

-inc lipoPHIlicity
-prolonged action upon IM or articular injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

21- Succinate group

A

-soluble
-slow hydrolysis (30-45min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

21- phosphate group

A

-inc solubility
-rapid hydrolysis by phosphatases (10min)
-IV or IM injection for emergency conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

1,2 double bond SAR

A

-inc GR to MR ratio by 5x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

11 B-OH SAR

A

-required for GR/MR activity
-more important for GR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
21-OH, F, Cl SAR
-required for activity -ester prodrug must be hydrolyzed to OH for max activity
26
17a-O SAR
-required for GR activity
27
16-O or B-CH3 SAR
-dec MR activity
28
9a-F or Cl SAR
-enhances GR and MR potency
29
6a-CH3 or F SAR
-enhances GR to MR ratio
30
Mech of glucocorticoid action in asthma
-will NOT stop attack while happening -inhibit airway inflammation -use prophylactically
31
GC effect on airway
-do not relax any muscle -mod cytokine and chemokine production -inhibit eicosanoid synthesis -inhibit accumulation of immune cells in lung -dec vascular permeability
32
inhaled gc
-use prophylactically -treat astma -max effects seen after weeks -compliance is concern
33
Desired properties of inhaled GCs
-high potency -minimal systemic affects -prolonged action
34
inhaled GC solutions
-high lipophilicity -low oral bioavailability (most is swallowed) -rapid clearance
35
high lipophilicity effect
-tighter binding -better penetration -prolonged action by forming microcrystals
36
inhaled GC drugs
-triamcinolone acetonide -beclomethasone dipropionate -Flunisolide -Budesonide -mometasone furoate -fluticasone propionate
37
Triamcinolone acetonide
-inhaled GC -resistant to hydrolysis -8x more potent than prednisolone
38
Beclomethasone dipropionate
-inhaled GC -converted rapidly to monopropionate by hydrolysis -14x more potent than dexamethasone
39
Flunisolide
-inhaled GC -rapid absorption -rapid metabolism (first-pass) -minimal adverse effect with long-term therapy
40
Budesonide
-inhaled GC -mixture of epimers at 16,17 butylacetal -faster topical uptake -low oral availability -extensive FP metabolism
41
Mometasone furoate
-inhaled GC -highly potent -more rapid onset -negligible availability (rapid metabolism and low oral bioavailability)
42
Fluticasone propionate
-inactivated by hydrolysis of thioester (FP metabolism) -highly lipoPHILIC -INsoluble -high potent -poor absorption from GI -rapid topical uptake
43
Desired properties of topical GCs
-high lipophilicity for fast absorption -minimal systemic effect -prolonged action
44
Topical GC metabolism
-absorbed thru skin -metabolized in liver -excreted to urine or bile
45
low potency topical GCs
-safest for chronic application -hydrocortisone cream
46
topical GCs with high potency
-risk systemic exposure -should be used only for short duration of treament
47
Halogenated analogues
-usually potent topical GCs
48
Topical GC forms
-acetonide/ester forms -21-chlorocorticoids -9a
49
Acetonide/ester topical GCs
-better potency bc high lipophilicity -triamcinolone acetonide -fluocinonide -betamethasone valerate
50
21-chlorocorticoids
-sub 21-OH with Cl -very high potency -topical anti-inflammatory
51
Fluticasone propionate and mometasone furoare
-topical GCs -medium potency -high lipophilicity but poor solubility -poor dissolution into inflamed tissue
52
Adverse effects of GCs
-crossover MC activity -metabolic effects -Cushing's-like effects -impaired glucose tolerance -immunosuppression -ulcer risk -CNS effects -cataracts -addisonian crisis
53
Adverse effect of GC crossover MC activity
-Na+ and water retention -HTN -correctable with selective GCs
54
Metabolic adverse effects of GC
-steroid myopathy -reduce bone growth in kids -osteoporosis
55
steroid myopathy
-high doses over time cause wasting of proximal muscles
56
Osteoporosis caused by GCs
-inhibit osteoblasts -can be prevented by bisphosphonate
57
Cushing's like effects
-redistribution of fat -moon face -buffalo hump
58
Impaired glucose tolerance form GCs
-HYPERglycemia from gluconeogenesis -dec insulin response (only diabetes)
59
Adverse effects of immunosuppression by GCs
-inc susceptibility -impaired healing
60
adverse effects of GCs on CNS
-linked to glucose metabolism -euphoria -depression
61
Addisonian crisis
-adrenal insufficiency upon GC withdrawal -delay recovery of hypothalmus and pituitary -dec ACTH release and response to ACTH -related to dose and duration of therapy
62
Addisonian crisis cause
-negative feedback on hypothalmus and pituitary from prolonged doses of GCs
63
Symptoms of Addisonian crisis
-inability to withstand stress -HYPOtension -weakness